Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention

In patients with chronic coronary syndrome, ticagrelor decreases cardiovascular events more efficiently than clopidogrel. In several studies investigating novel P2Y12 inhibitors dyspnea has been detected. A rise of adenosine blood levels is supposed to be one of cases of dyspnea induced by ticagrelo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dunya Habeeb Shnain, Ghassan Mohammed Mahmood, Sara Omar Ahmed
Formato:	Artigo
Idioma:	Russo
Publicado em:	«SILICEA-POLIGRAF» LLC 2024-06-01
coleção:	Кардиоваскулярная терапия и профилактика
Assuntos:	dyspnea ticagrelor clopidogrel chronic coronary syndrome coronary intervention
Acesso em linha:	https://cardiovascular.elpub.ru/jour/article/view/3970
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!